Industry Symposia

Tuesday, April 20, 2010: 12:00 – 2:00 PM

When Antidepressants Fall Short: Augmentation Strategies in Major Depressive Disorder

Learning Objectives

At the conclusion of this application-based activity, participants will be able to:

  1. Describe epidemiology of Major Depressive Disorder (MDD) and negative impact of partial response or treatment resistance.
  2. Recognize the importance of remission in MDD and identify strategies to improve remission rates.
  3. Outline evidence for use of atypical antipsychotics when conventional antidepressants fail.
  4. In a case-based approach, formulate augmentation strategies for patients with MDD who do not respond to first-line therapies.

Back

Agenda

12:00-12:30 PM Registration & Seating/Meal Function
12:30-12:35 PM

Welcome & Introductions
Leigh Anne Nelson, PharmD, BCPP (Activity Chair)

12:35-12:50 PM Unmet Needs: Augmentation Strategies and the Continued Gap Between Success & Failure
Leigh Anne Nelson, PharmD, BCPP
12:50-1:15 PM Role of Atypical Antipsychotics in MDD: What Does the Literature Say?
J. Craig Nelson, MD
1:15-1:45 PM Augmentation Strategies in Clinical Practice: Case Studies
Roger S. McIntyre, MD, FRCPC & Faculty Panel
1:45-2:00 PM Discussion/Q&A

Back

Registration

Registration will be accepted on a first-come, first-served basis onsite; therefore, pre-registration is not required. Doors will open at 12:00 PM.

There is no registration fee to attend this activity.

Back

Accreditation and Designation of Credit

Creative Educational Concepts, Inc (CEC) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity has been assigned ACPE #0245-0000-10-002-L01-P and will award 1.5 contact hours (0.15 CEUs) of continuing education credit. CEC complies with the Criteria for Quality for continuing education programming. Statements of credit will be issued to those participants attending the activity and completing a CE request form and will be mailed within 10 business days.

Back

Additional Information

Additional information available at www.ceconcepts.net/cpnp

Supported By

(Supported by an independent educational grant from AstraZeneca)

Back